Viewing Study NCT01026493


Ignite Creation Date: 2025-12-25 @ 1:18 AM
Ignite Modification Date: 2026-05-30 @ 5:01 AM
Study NCT ID: NCT01026493
Status: COMPLETED
Last Update Posted: 2017-07-02
First Post: 2009-12-03
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
Sponsor: Radiation Therapy Oncology Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult giant cell glioblastoma View
None adult glioblastoma View
None adult gliosarcoma View
None recurrent adult brain tumor View
None adult anaplastic astrocytoma View
None adult anaplastic ependymoma View
None adult anaplastic oligodendroglioma View
None adult brain stem glioma View
None adult mixed glioma View
None adult pineal gland astrocytoma View